Vaccinating pregnant mothers could avert 31,000 deaths and save $385m in healthcare costs, it is estimated; A global maternal immunisation programme for group B Streptococcus – Strep B – would save millions of dollars in healthcare costs by reducing death and disability, a team led by researchers from the London Read more…
We are pleased to announce that Meningitis Research Foundation’s biennial conference will be held on the 7th – 8th November 2023 at the British Museum in London. This will be our fourteenth international conference and will bring world leading experts together to share the latest advances and discuss today’s challenges Read more…
Why do we need to step forward towards a maternal GBS-vaccine? By May Murra, Aarhus University Hospital, Denmark and Dr Eleni Vergadi, University of Crete, Medical School Global impact of GBS in mothers, neonates, and infants Globally, around 20% of pregnant women (approximately 20 million women each year) are colonized Read more…
By Javairia Khalid, Lecturer, The Aga Khan University, Pakistan Dr Javairia Khalid, a member of the ‘Young ISSAD’ Committee, has created a handy infographic regarding the symptoms of GBS disease in newborns compared to people of other ages who get GBS disease. Please find the downloadable infographic below.
MinervaXApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces the successful completion of a 72 million EUR financing round. The equity financing of 22 million EUR was co-led by new investors Trill Impact Ventures and Pureos Bioventures and includes existing investors Read more…
Abstracts are now being accepted for the above annual virtual conference, which brings together experts from the UK and around the world to share knowledge and discuss the latest developments in this field. This conference will provide a platform for researchers to present the latest findings in Group B Strep Read more…
By Javairia Khalid, Lecturer, The Aga Khan University, Pakistan An estimated one in five pregnant women around the world carry Group B Streptococcus (GBS) bacteria which is a major, yet preventable, cause of maternal and infant ill health globally. GBS is not a sexually transmitted disease and can be found Read more…
New data published in MBRRACE-UK’s Perinatal Mortality Surveillance Report 2020 has found that group B Strep is the most commonly identified cause of stillbirth and neonatal death. For the first time, data were presented on infectious causes of stillbirth and neonatal death, which showed that group B Strep is the Read more…
By Javairia Khalid, Lecturer, The Aga Khan University, Pakistan Each year on November 17th, World Prematurity Day is observed to raise awareness about preterm birth and what these babies and their families face across the world. Approximately 15 million babies are born preterm each year, which accounts for over 1 Read more…
Thursday 17 November9am EST | 2pm GMT | 3pm CET | 5pm EAT | 7:30pm IST (1 hour) Thank you for joining us for our 1st ‘Young ISSAD’ Committee Seminar Series on GBS Epidemiology. We had speakers Dr Proma Paul, London School of Hygiene & Tropical Medicine and Dr Lesly Read more…